Designing bioactive delivery systems for tissue regeneration.
The direct infusion of macromolecules into defect sites generally does not impart adequate physiological responses. Without the protection of delivery systems, inductive molecules may likely redistribute away from their desired locale and are vulnerable to degradation. In order to achieve efficacy, large doses supplied at interval time periods are necessary, often at great expense and ensuing detrimental side effects. The selection of a delivery system plays an important role in the rate of re-growth and functionality of regenerating tissue: not only do the release kinetics of inductive molecules and their consequent bioactivities need to be considered, but also how the delivery system interacts and integrates with its surrounding host environment. In the current review, we describe the means of release of macromolecules from hydrogels, polymeric microspheres, and porous scaffolds along with the selection and utilization of bioactive delivery systems in a variety of tissue-engineering strategies.
Davis
Hillary E
HE
Department of Biomedical Engineering, University of California, Davis, 451 Health Sciences Drive, 2303 Genome and Biomedical Sciences Facility, Davis, CA, 95616, USA.
Leach
J Kent
JK
D000818:Animals; D004337:Drug Carriers / Q000138:chemical synthesis*; D048091:Guided Tissue Regeneration / Q000639:trends*; D006801:Humans; D023822:Tissue Engineering / Q000639:trends*; D054457:Tissue Scaffolds / Q000639:trends*
D004337:Drug Carriers